Skip to content

Public FDA record

Z-2036-2018: AmerisourceBergen PF Latex SG (Surgical Glove), Sterile, Powder Free, Size 6.5, Item No. 10112

Recall record Z-2036-2018 for WRP Asia Pacific Sdn Bhd. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2036-2018
Company in FDA record
WRP Asia Pacific Sdn Bhd
FDA record creation date
May 30, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some left-handed gloves contain powder. Powdered surgical gloves are a banned medical device in the U.S. Powder on natural rubber latex gloves can aerosolize latex allergens, resulting in sensitization to latex and allergic reactions. Additional risks of powdered gloves include severe airway inflammation, conjunctivitis, dyspnea, as well as granuloma and adhesion formation when exposed to internal tissue.

Source facts

Action
On May 7, 2018, WRP (contract manufacturer) issued an Urgent Medical Device Recall notice to its affected customer. The customer then notified its U.S. consignee, American Health Packaging, which in turn disseminated the recall information to affected consignees, down to the user level. The following instructions were provided to affected customers: If you are a Distributor: 1. Immediately examine your inventory, quarantine and discontinue distribution of these lots. 2. Carry out a physical count and record this data on the Business Reply Card and the Packing slip, which are included with this letter. Complete the enclosed Business Reply Card even if you do not have any product on hand. 3. Please pass this Recall Notice on ONLY to users that received these product lots. 4. Return the recalled product and the Packing Slip using the prepaid FedEx shipping labels to: GENCO Pharmaceutical Services a subsidiary of FedEx Supply Chain 6101 North 64th Street Milwaukee, WI 53218 If you are a User: 1. Immediately examine your inventory, quarantine and discontinue distribution of these lots. 2. If you have units of the affected products/lots in inventory, please contact GENCO Pharmaceutical Services at 877-319-8964 to receive a recall return packet. If you have not received this product you do not need to request a return packet. 3. Carry out a physical count and record this data on the Business Reply Card and the Packing slip, which are included with this letter. 4. You do not need to contact any patients. 5. Return the recalled product and the Packing Slip using the prepaid FedEx shipping labels to: GENCO Pharmaceutical Services a subsidiary of FedEx Supply Chain 6101 North 64th Street Milwaukee, WI 53218 To receive credit, the reply form and recalled product must be returned to GENCO by August 16th, 2018. For questions about the recall process, call GENCO Pharmaceutical Services at (877) 319-8964.
Initiated
2018-05-07
Root cause
Process control
Terminated
2019-05-30
Distribution
Distributors in AL, CA, OH, ID, KS, MN, NC, PA, TX.
Recall number
Z-2036-2018
Recall status
Terminated
CDRH record ID
164146
FDA record created
2018-05-30
Recall event number
79992

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗